ORGENTEC Diagnostika | news and press releases
Short news: Branding identity
- Details
ORGENTEC Diagnostika GmbH is part of the Sebia Group and will adhere to the Sebia branding identity, consequently.
Visit us at the 14th International Congress on Autoimmunity and find us in the new Sebia booth design
- Details
Sebia acquires ORGENTEC Diagnostika
- Details
The strategic acquisition reinforces Sebia’s global leadership in specialty diagnostics
Alegria® Check: For quality asurance in the lab
- Details
Mainz, Germany – ORGENTEC offers efficient tools for routine quality control of Alegria® assays in autoimmune disease diagnostics.
How ORGENTEC is handling the COVID-19 challenge
- Details
Mainz, Germany – As COVID-19 continues to impact the globe, ORGENTEC is positioned and prepared to make sure that we continue our business during this difficult period.
Driving commercial success
- Details
Mainz, Germany – ORGENTEC appoints John Garland Director International Sales.
ORGENTEC Diagnostika appoints global healthcare leader Gary Winer as president and CEO
- Details
Mainz, Germany – ORGENTEC Diagnostika, a leading specialty diagnostics company, announced today that its board of directors has appointed Gary Winer to president and chief executive officer, effective immediately. Mr. Winer will leverage his global healthcare leadership experience to further ORGENTEC’s long-term growth and position as one of the world’s premier providers of diagnostic assays specializing in autoimmune and infectious diseases
New Member in the ORGENTEC Management Crew
- Details
Mainz – Dr. Klaus Esperschidt is ready to join ORGENTEC as Vice President Operations.
Starting in Mid-September he will join the ORGENTEC company management and strengthen the operative activities of the company.
He takes over the position from Dr. Michael Bartels, who will switch to the position of Vice President Commercials.
ORGENTEC strengthens global business activities
- Details
Mainz, Germany – Frederic W.P. Paquet has been appointed Director Sales International.
Workshop for Students at ORGENTEC Diagnostika
- Details
Mainz, Germany – University and Business Company – Meeting of two Worlds: Once again, students from Rhein Main University of Applied Sciences visited ORGENTEC Diagnostika to gain insights into the working world of a global medical technology company. Lectures, experiments and discussions were building bridges between everyday research, university and business – a successful initiative by biotechnology lecturer Prof. Ulrike Stadtmueller and the general management of ORGENTEC. The students learned about requirements and perspectives in the diagnostics industry and gained an impressive look behind the scenes of an international company.
ORGENTEC expands its executive management by Dr. Michael Bartels
- Details
Mainz, Germany – Effective April 1, 2017, Dr. Michael Bartels, VP Operations, will strengthen the executive management of ORGENTEC Diagnostika GmbH.
ORGENTEC Strengthens Global Management Team
- Details
Mainz, Germany – We cordially welcome Dr. Michael Bartels who joins ORGENTEC Diagnostika in the role of Vice President Operations at the company’s headquarters in Mainz.
ORGENTEC Diagnostika presents achievements in biomarker discovery within the EuroTEAM research project at this year’s EULAR congress in London
- Details
Mainz, Germany – ORGENTEC Diagnostika has a leading role in the prestigious research project EuroTEAM Arthritis (Towards Early diagnosis and biomarker validation in Arthritis Management), funded by the European Union with more than 5.7 million EUR for four years. Together with partners from 13 renowned European research institutions we present the progress of the project and our contribution to the discovery of novel biomarkers for rheumatoid arthritis at the EuroTEAM stand in the EULAR village from June 08-11.
Internationalizing ORGENTEC follows the MEDICA trend
- Details
New products and brand growth win over industry visitors
ORGENTEC and Corgenix Launch Combined Operations at 2015 AACC Clinical Lab Expo
- Details
Merger of ORGENTEC Diagnostika and Corgenix Medical creates a global distribution network and offers more than 350 diagnostic assays
Mainz, Germany – The global diagnostics industry is welcoming ORGENTEC Diagnostika and Corgenix Medical Corporation to the 2015 American Association of Clinical Chemistry (AACC) Clinical Lab Expo in booth #3711. ORGENTEC completed its acquisition of Corgenix in March 2015 and is exhibiting for the first time at AACC. The combined specialty diagnostics company features a portfolio of more than 350 diagnostic tests, including ELISA, IFA, LFI, IT and immunoblot.
ORGENTEC Diagnostika has finalized its acquisition of Corgenix Inc.
- Details
Corgenix Transfers to ORGENTEC Exclusive Worldwide Distribution Rights. Effective July 1st.
Celebrating 10 years of joy with Alegria®
- Details
1000th laboratory device ships to Argentina as a regional art edition
Acquisition of Corgenix Completed by ORGENTEC Diagnostika
- Details
US Affiliate Expands Specialty Diagnostics Company’s Global Presence and Test Menu
MEDICA Update - Liver-9-Line 2nd Generation
- Details
Mainz / Düsseldorf - At the world’s biggest trade show for medical technology MEDICA commencing on 12th of November, ORGENTEC joins over 4500 other international exhibitors displaying latest projects and innovations. Therefore, we may give you an update on ORGENTEC’s most recent product developments!
MEDICA Update – Calprotecin for ELISA
- Details
Mainz / Düsseldorf - At the world’s biggest trade show for medical technology MEDICA commencing on 12th of November, ORGENTEC joins over 4500 other international exhibitors displaying latest projects and innovations. Therefore, we may give you an update on ORGENTEC’s most recent product developments!
Corgenix Enters into Agreement to be Acquired by ORGENTEC Diagnostika
- Details
ORGENTEC acquires Corgenix
Corgenix Enters into Agreement to be Acquired by ORGENTEC Diagnostika
- Corgenix shareholders to receive $0.27 in cash per share
- Transaction valued at approximately $16 million
- Following the transaction, Corgenix will remain headquartered in Broomfield, Colo., as a subsidiary of Orgentec Diagnostika
- Strategic Acquisition Creates Leading Global Specialty Diagnostics Company
Employer’s Day at ORGENTEC
- Details
Employer’s Day at ORGENTEC Diagnostika – Students get a Taste of the Laboratory at the Mainz Company Headquarters
Mainz - Students from the RheinMain University of Applied Sciences crossed the Rhine for a glimpse of the working world in a Medical Technology company with global reach.
In presentations and discussions with the visitors from the Ruesselsheim campus, a bridge was constructed between the reality of research, the university, and scientific thinking – a successful initiative driven by Biotechnology Professor Dr. Ulrike Stadtmüller and the directors of ORGENTEC.
Water Street Invests in Orgentec Diagnostika
- Details
Water Street Invests in Orgentec Diagnostika
Health Care Firm Partners with European Specialty Diagnostics Company; Former Beckman Coulter Chairman & CEO to Serve as Chairman